Envisioning a world where all can see a brighter future.

KeraLink International (KLI) works to prevent, detect and treat corneal disease and blindness by providing innovative and affordable solutions and technologies to underserved populations in lower-and middle-income countries. KLI unites clinicians, technology innovators, social entrepreneurs, and donors in a coordinated and collaborative effort to address this silent, yet treatable disease. Ultimately, the organization envisions a world where all can see a brighter future.
0 MILLION +

People worldwide are living with corneal blindness

0 %

Of people with corneal blindness live in low- and middle-income countries (LMICs)

0 %

Of people who need a cornea transplant in low- and middle-income countries (LMICs) will not get one

Corneal blindness is preventable, treatable, and reversible.

No one needs to be blind due to corneal disease or injury.

However, treatment and care for corneal diseases and injuries are often inaccessible or unaffordable in low- and middle-income countries (LMICs).

CAUSES & CONSEQUENCES

Corneal blindness can be caused by infection, injury, inflammation, or inherited conditions. It primarily impacts young people in LMICs and has profound social and economic consequences, including:

icon1

Reduced Quality of Life

icon2

Educational Barriers

icon3

Loss of Productivity

icon4

Gender Disparities

icon5

Increased Healthcare Costs

THE PEN STRATEGY

We use a collaborative three-pronged approach for holistic cornea care.

PREVENTION

We work to prevent injuries and infections that can lead to corneal blindness

Conditions Targeted for Prevention

EARLY DETECTION & RAPID TREATMENT

Stopping corneal conditions from advancing to visual impairment and blindness

Conditions Targeted in Early Detection

NOVEL TREATMENTS & TECHNOLOGY

Preserving & restoring sight using affordable & sustainable novel treatments

Treatments Being Developed

Scroll to Top